Skip to content
★ Sign in to follow
GH

Gösta Hiller

Cinclus Pharma Holding AB (publ)
Insider activity · 24 months2 buys0 salesCumulative net flow
Total declarations
4
Company
1
▲ Purchases (4 ops.)
€6,704
▼ Sales (0 ops.)
—

Latest filing published 08 Jun 2026 for Cinclus Pharma Holding AB (publ), €1,130.

Filing timeline

BuySale
Gösta Hiller

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

Closed purchases

Market purchases
4
Positive at T+90
100%
Median T+90
+4.0%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Gösta Hiller: trading record in brief

This profile gathers the share dealings of Gösta Hiller in Cinclus Pharma Holding AB (publ). Over a trading history stretching from 5 June 2026 to 8 June 2026, the count stands at 4 filings.

No open-market sale appears; the market trades are 4 purchases worth €6,704. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

In size, the median ticket on the buying side is €1,676. Scaled by market value, the purchases weigh a median 0.0023% of market cap (sample: 3 purchases).

The record was last updated on 8 June 2026 with an open-market purchase (€1,130) in Cinclus Pharma Holding AB (publ). The median gap between trade and publication is zero days: most filings appear on the same day. For comparison, MAR article 19 gives managers three business days to notify a trade. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.

Companies and markets linked to Gösta Hiller

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Annan ledande befattningshavareExecutivesCinclus Pharma Holding AB (publ)
    12,380 SEK29FI-SE
    1,000 shares@ SEK 12.380.0023% mcap33.7% of flowAktieISIN SE0020388577FI:A003Z677-1
    Canonical exit: 6 Sept 2026 (T+90)
  • ▲
    Annan ledande befattningshavareExecutivesCinclus Pharma Holding AB (publ)
    24,280 SEK33FI-SE
    2,000 shares@ SEK 12.1466.3% of flowAktieISIN SE0020388577FI:A003Z635-1
    Canonical exit: 3 Sept 2026 (T+90)

2 of 2 declarations